Martin Haupt

Summary

Country: Germany

Publications

  1. ncbi Quality of life as an outcome in Alzheimer's disease and other dementias--obstacles and goals
    Matthias W Riepe
    Department of Psychiatry and Psychotherapy II, Mental Health and Old Age Psychiatry, Ulm University, Ulm, Germany
    BMC Neurol 9:47. 2009
  2. ncbi [Psychiatric disorders in rheumatic diseases, as exemplified by systemic lupus erythematosus (SLE)]
    M Haupt
    Neuro Centrum Düsseldorf, Lehrpraxis der Klinik und Poliklinik für Psychiatrie und Psychotherapie der Heinrich Heine Universität, Hohenzollernstr 1 5, 40211 Düsseldorf, Germany
    Z Rheumatol 63:122-30. 2004
  3. ncbi [Diagnostics and treatment of delirium tremens--not caused by alcohol or other psychotropic substances]
    M Haupt
    , , Hohenzollernstrasse 1-5,
    Fortschr Neurol Psychiatr 74:49-57; quiz 58-62. 2006
  4. ncbi [Combined medical treatment and psychotherapy in early-stage Alzheimer's over a period of 30 months]
    M Haupt
    Neuro Centrum Düsseldorf
    Nervenarzt 77:842-6. 2006
  5. ncbi Mortality in elderly dementia patients treated with risperidone
    Martin Haupt
    Department of Cognitive Disorders, Neurologic Research Institute, Neuro Centrum Düsseldorf, Dusseldorf, Germany
    J Clin Psychopharmacol 26:566-70. 2006
  6. ncbi [Elderly patient becomes increasingly forgetful: is it early dementia?]
    M Haupt
    ,
    MMW Fortschr Med 149:42-3. 2007
  7. ncbi Regions with different evoked frequency band responses during early-stage visual processing distinguish mild Alzheimer dementia from mild cognitive impairment and normal aging
    M Haupt
    Department of Cognitive Disorders, Neuro Centrum Düsseldorf, Neurologic Research Institute, Dusseldorf, Germany
    Neurosci Lett 442:273-8. 2008

Collaborators

  • Dilip Jeste
  • Matthias W Riepe
  • Christoph Vauth
  • Hans Forstl
  • Reiner Leidl
  • Thomas Mittendorf
  • Matthias Graf von der Schulenburg
  • Lutz Frolich

Detail Information

Publications7

  1. ncbi Quality of life as an outcome in Alzheimer's disease and other dementias--obstacles and goals
    Matthias W Riepe
    Department of Psychiatry and Psychotherapy II, Mental Health and Old Age Psychiatry, Ulm University, Ulm, Germany
    BMC Neurol 9:47. 2009
    ..g. severity of symptoms or frequency of complications of a disease. However, this does not allow clear judgement on clinical relevance or comparison across different diseases...
  2. ncbi [Psychiatric disorders in rheumatic diseases, as exemplified by systemic lupus erythematosus (SLE)]
    M Haupt
    Neuro Centrum Düsseldorf, Lehrpraxis der Klinik und Poliklinik für Psychiatrie und Psychotherapie der Heinrich Heine Universität, Hohenzollernstr 1 5, 40211 Düsseldorf, Germany
    Z Rheumatol 63:122-30. 2004
    ..Therapeutic interventions in SLE should consist of a combined pharmacological and nonpharmacological treatment. Corticosteroid drugs, however, may be effective in alleviating mild psychiatric symptoms as well...
  3. ncbi [Diagnostics and treatment of delirium tremens--not caused by alcohol or other psychotropic substances]
    M Haupt
    , , Hohenzollernstrasse 1-5,
    Fortschr Neurol Psychiatr 74:49-57; quiz 58-62. 2006
  4. ncbi [Combined medical treatment and psychotherapy in early-stage Alzheimer's over a period of 30 months]
    M Haupt
    Neuro Centrum Düsseldorf
    Nervenarzt 77:842-6. 2006
    ....
  5. ncbi Mortality in elderly dementia patients treated with risperidone
    Martin Haupt
    Department of Cognitive Disorders, Neurologic Research Institute, Neuro Centrum Düsseldorf, Dusseldorf, Germany
    J Clin Psychopharmacol 26:566-70. 2006
    ..Larger studies would be needed to rule out a small increase in mortality in these patients. Careful assessments of potential benefits and risks should be made before prescribing risperidone for the treatment of BPSD...
  6. ncbi [Elderly patient becomes increasingly forgetful: is it early dementia?]
    M Haupt
    ,
    MMW Fortschr Med 149:42-3. 2007
  7. ncbi Regions with different evoked frequency band responses during early-stage visual processing distinguish mild Alzheimer dementia from mild cognitive impairment and normal aging
    M Haupt
    Department of Cognitive Disorders, Neuro Centrum Düsseldorf, Neurologic Research Institute, Dusseldorf, Germany
    Neurosci Lett 442:273-8. 2008
    ..Because the method applied in this work differentiates among clinical entities with varying severity of cognitive decline, it may eventually serve as an electrophysiological marker in the early detection of neurodegeneration...